Entera Bio Ltd
NASDAQ:ENTX
Entera Bio Ltd
PP&E Net
Entera Bio Ltd
PP&E Net Peer Comparison
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Entera Bio Ltd
NASDAQ:ENTX
|
PP&E Net
$488k
|
CAGR 3-Years
-4%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
PP&E Net
$5.9m
|
CAGR 3-Years
6%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
PP&E Net
$38.4m
|
CAGR 3-Years
10%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
PP&E Net
$1.9m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
10%
|
Urogen Pharma Ltd
NASDAQ:URGN
|
PP&E Net
$2m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
PP&E Net
₪18.1m
|
CAGR 3-Years
47%
|
CAGR 5-Years
79%
|
CAGR 10-Years
28%
|
See Also
What is Entera Bio Ltd's PP&E Net?
PP&E Net
488k
USD
Based on the financial report for Dec 31, 2023, Entera Bio Ltd's PP&E Net amounts to 488k USD.
What is Entera Bio Ltd's PP&E Net growth rate?
PP&E Net CAGR 5Y
17%
Over the last year, the PP&E Net growth was 112%. The average annual PP&E Net growth rates for Entera Bio Ltd have been -4% over the past three years , 17% over the past five years .